SOX9 and central nervous system cancer: The TargetScan Program suggested that the 3′UTR region of the SOX9 gene containing the binding sites of miR-101 (Figure 3A), and the expression level of SOX9 in glioma (II-III) tissue was higher than that of the normal brains tissue (Figure 3B and Supplementary Figure 5).